Human brain expresses more than 70% of microRNAs, aberrant expression of which have been shown to associate with the pathological progression of AD by modulating amyloidogenesis and Tau pathology, as well as unknown molecular pathways [39]. The gene discussed is MAPT; the disease is Alzheimer disease.